Watchlist

GENE.01

Name: GENE.01
Brand: Generative Bionics

An Italian IIT spin-off with a touch-sensing skin; first shipyard welding trials are due by end of 2026.

EUPrototype–

USNot available–

CNNot available–

GENE.01 humanoid, head and upper body in two colour variants · Photo: Fincantieri / Generative Bionics · Press image · Source

Generative Bionics showed GENE.01 at AMD's CES 2026 keynote on 2026-01-06, a European humanoid with a full-body sensing skin. Its first named partner is shipbuilder Fincantieri, with a four-year programme (announced 2026-02-11) to develop a welding variant and begin on-site trials at the Sestri Ponente yard by end of 2026. Eni signed a memorandum of understanding on 2026-09-30; Eni is also an investor, not a customer. Specs and price have not been officially published.

Our verdict

A well-funded European newcomer with a real industrial partner and a defensible safety idea; still a development programme. Move to core if the Fincantieri trials start on schedule.

Maker: Generative Bionics
HQ: Genoa, Italy
Locomotion: Two legs
Use: Manufacturing, Inspection
Confidence: Medium
Last reviewed: Nov 1, 2026

Inclusion criteria met

Purchasable in EU/US with a public priceNo price and no order channel. A price estimate of about USD 50,000 on a wiki site is unofficial. A commercial launch in Q4 2026 appears in a secondary compilation, not in a company statement.
Deployed at a named customerFincantieri is a named partner (press release, 2026-02-11), but the programme is joint development, with first on-site trials only planned by end-2026. Eni (MoU 2026-09-30) is to assess collaboration and is also an investor. Neither is a deployment yet, so criterion 2 is not met. Re-check at the start of 2027.
Serious developer with real, uncut videoEUR 70M funding led by a state-backed fund, AMD as technology partner, working hardware shown on stage at CES 2026. Real uncut footage of tasks was not checked.

Compare with others

Video

**GENE.01 Design Concept at CES 2026**
Generative Bionics

**Gene.01 Demo for Lisa Su (AMD Chair & CEO) - AMD Advancing AI 2026**
Generative Bionics

**[Six-Month Update]: GENE.01 Comes to Life**
Generative Bionics

**[Three-Month Update]: Motion Intelligence via RL on different GENE.01 Lower-Body Platforms**
Generative Bionics

Availability

EuropePrototype

No public price

No price. Company has not stated a firm commercial date.

as of 2026-10 · Source

United StatesNot available

No public price

No US plan found.

as of 2026-10 · Source

ChinaNot available

No public price

No China plan found.

as of 2026-10 · Source

Deployments

Customer	Location	Type	Since	Source
Fincantieri Four-year partnership to develop a humanoid welding robot; initial on-site trials planned by end of 2026, operational functions within two years. Development stage, no trial reported yet. The press release does not name GENE.01; it is a development partnership, nothing deployed yet.	Sestri Ponente shipyard, Genoa, Italy	Agreement	Feb 2026	fincantieri.com
Eni MoU to analyse and test collaboration on humanoids for inspection, teleoperation and complex environments, starting with GENE.01. Eni is also an investor via Eni Next.	Italy	Agreement	Sep 30, 2026	chemxplore.com

Timeline

Jul 2024
Generative Bionics founded as an IIT spin-off.
Dec 2025
EUR 70M funding round closes, led by CDP Venture Capital.
Jan 6, 2026
GENE.01 unveiled at AMD's CES 2026 keynote.
Feb 11, 2026
Four-year partnership with Fincantieri for a humanoid welding robot announced.
Jul 28, 2026
Company describes GENE.01 as a fully functional smart-skin platform; Synapticon named for European actuator supply.
Sep 30, 2026
MoU signed with Eni.

Promises

Fincantieri / Generative Bionics · Feb 2026Pending

“Initial on-site trials of the humanoid welding robot at Sestri Ponente by end of 2026”

No trial reported as of 2026-10-31.

Due Dec 2026 · Source

Generative Bionics (via secondary compilation) · 2026Pending

“Commercial launch in Q4 2026 (reported by third parties; the company names no quarter)”

Not found in any company statement; the company's own materials describe a platform ready to enter its commercialization pipeline without a date. A third-party product guide mentions a commercial launch in late 2026. Treat as unconfirmed.

Due Dec 2026 · Source